<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinic-experimental complex investigation and ELISA determination of protein HLDF as also primary antibodies (Abs) to HLDF values in blood and cerebro-spinal fluid (CSF) of patients with hypertensive crises and <z:hpo ids='HP_0011009'>acute</z:hpo> aterotrombotic <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> were performed </plain></SENT>
<SENT sid="1" pm="."><plain>Statistically improved difference in serum HLDF and Abs content in examined patients in comparison with age-matched controls as also significant intergroup's differences in protein and Abs dynamic content were determined </plain></SENT>
<SENT sid="2" pm="."><plain>Correlation between content and dynamics of investigated factors in CSF and blood serum with determined clinical and instrumental parameters was revealed </plain></SENT>
<SENT sid="3" pm="."><plain>Pathogenetic and prognostic significance of revealed changes in molecular factors was viewed </plain></SENT>
</text></document>